These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 36069578)

  • 21. Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases.
    Spyrakis F; Santucci M; Maso L; Cross S; Gianquinto E; Sannio F; Verdirosa F; De Luca F; Docquier JD; Cendron L; Tondi D; Venturelli A; Cruciani G; Costi MP
    Sci Rep; 2020 Jul; 10(1):12763. PubMed ID: 32728062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria.
    Khan AU; Ali A; Danishuddin ; Srivastava G; Sharma A
    Sci Rep; 2017 Aug; 7(1):9207. PubMed ID: 28835636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A close look onto structural models and primary ligands of metallo-β-lactamases.
    Raczynska JE; Shabalin IG; Minor W; Wlodawer A; Jaskolski M
    Drug Resist Updat; 2018 Sep; 40():1-12. PubMed ID: 30466711
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Kaya C; Konstantinović J; Kany AM; Andreas A; Kramer JS; Brunst S; Weizel L; Rotter MJ; Frank D; Yahiaoui S; Müller R; Hartmann RW; Haupenthal J; Proschak E; Wichelhaus TA; Hirsch AKH
    J Med Chem; 2022 Mar; 65(5):3913-3922. PubMed ID: 35188771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.
    Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM
    J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Peptide-based Metallo-β-lactamase Inhibitors as a New Strategy to Combat Antimicrobial Resistance: A Mini-review.
    Cheng Q; Zeng P; Chi Chan EW; Chen S
    Curr Pharm Des; 2022; 28(44):3538-3545. PubMed ID: 36177630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.
    Brindisi M; Brogi S; Giovani S; Gemma S; Lamponi S; De Luca F; Novellino E; Campiani G; Docquier JD; Butini S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):98-109. PubMed ID: 27121013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant
    Lomovskaya O; Rubio-Aparicio D; Tsivkovski R; Loutit J; Dudley M
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0216821. PubMed ID: 34902261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-
    Lee T; Lee S; Kim MK; Ahn JH; Park JS; Seo HW; Park KH; Chong Y
    ACS Infect Dis; 2024 May; 10(5):1624-1643. PubMed ID: 38652574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
    Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
    ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of aspergillomarasmine A/meropenem combinations with and without avibactam against bacterial strains producing multiple β-lactamases.
    Rotondo CM; Wright GD
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0027224. PubMed ID: 39133022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D).
    Romero E; Oueslati S; Benchekroun M; D'Hollander ACA; Ventre S; Vijayakumar K; Minard C; Exilie C; Tlili L; Retailleau P; Zavala A; Elisée E; Selwa E; Nguyen LA; Pruvost A; Naas T; Iorga BI; Dodd RH; Cariou K
    Eur J Med Chem; 2021 Jul; 219():113418. PubMed ID: 33862516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors.
    Gavara L; Legru A; Verdirosa F; Sevaille L; Nauton L; Corsica G; Mercuri PS; Sannio F; Feller G; Coulon R; De Luca F; Cerboni G; Tanfoni S; Chelini G; Galleni M; Docquier JD; Hernandez JF
    Bioorg Chem; 2021 Aug; 113():105024. PubMed ID: 34116340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational modelling of potential Zn-sensitive non-β-lactam inhibitors of imipenemase-1 (IMP-1).
    Ayipo YO; Ahmad I; Alananzeh W; Lawal A; Patel H; Mordi MN
    J Biomol Struct Dyn; 2023 Nov; 41(19):10096-10116. PubMed ID: 36476097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing intermolecular interactions and binding stability of antimicrobial peptides with beta-lactamase of
    Chakkyarath V; Natarajan J
    J Biomol Struct Dyn; 2022; 40(24):13641-13657. PubMed ID: 34676806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
    Everett M; Sprynski N; Coelho A; Castandet J; Bayet M; Bougnon J; Lozano C; Davies DT; Leiris S; Zalacain M; Morrissey I; Magnet S; Holden K; Warn P; De Luca F; Docquier JD; Lemonnier M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-lactamase inhibitors: the story so far.
    Pérez-Llarena FJ; Bou G
    Curr Med Chem; 2009; 16(28):3740-65. PubMed ID: 19747143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases.
    Yan YH; Li ZF; Ning XL; Deng J; Yu JL; Luo Y; Wang Z; Li G; Li GB; Xiao YC
    Bioorg Med Chem Lett; 2021 Jun; 41():127956. PubMed ID: 33744439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
    Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.